A Phase II Open-Label, Single-Arm, Two Stage, Multicenter Trial of Pracinostat in Combination With Azacitidine in Elderly (Age ≥ 65 Years) Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)
The specific purpose of this study is to find out what effects, good and bad, the study drug in combination with azacitidine has on participants with newly diagnosed acute myeloid leukemia (AML).
Newly diagnosed AML.
65 or Greater Years of Age with Newly Diagnosed AML.
65 - 110
Healthy Volunteers Needed
Duration of Participation
Participants will be seen every three months in clinic until their leukemia gets worse.
Nan Subbiah 503-494-4603
Clinical Trials Information Line: Phone 503-494-1080 or email@example.com
MEI Pharma, Inc.